Statistics for Treace Medical Concepts, (id:7658 TMCI)

Valuation metrics

Market cap

493.39M

Enterprise value

462.65M

Trailing P/E (ttm)

-9.85

Forward P/E

-10.17

PEG ratio

-10.17

Price/Sales (ttm)

2.43

Price/Book (mrq)

4.53

Enterprise Value/Revenue

2.28

Enterprise Value/EBITDA

-8.47

Overview

Shares outstanding

62.30M

Float

45.69M

Shares short

4.94M

% Held by insiders

0.25%

% Held by institutions

0.64%

Average volume (10 days)

1.11M

Average volume (90 days)

Price summary

52-Week low

3.92

52-Week high

15.98

52-Week change

-11.15%

Beta

0.24

50-Day moving average

5.58

200-Day moving average

8.30

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-30.33%

Operating margin

-33.57%

Operational effectiveness

Return on assets

-17.13%

Return on equity

-50.68%

Income statement

Revenue (ttm)

3.27

Revenue per share (ttm)

3.27

Quarterly revenue growth (yoy)

Gross profit (ttm)

151.94M

EBITDA

-54,627,000.00

Net income to common (ttm)

-61,523,000.00

Diluted EPS (ttm)

-0.95

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

82.80M

Total cash per share (mrq)

1.33

Total debt (mrq)

70.12M

Total Debt/Equity (mrq)

66.84

Current ratio (mrq)

411.90%

Book value per share (mrq)

1.68

Cash flow

Cash flow statement

-32,428,000.00

Levered free cash flow (LFCF)

-20,632,124.00